KẾT QUẢ ĐIỀU TRỊ VIÊM DA DẦU BẰNG TACROLIMUS BÔI TẠI CHỖ

Abstract

Background and Aims: Seborrheic dermatitis is a common chronic inflammatory skin disease impacting quality of life. This study aimed to evaluate the efficacy of topical tacrolimus in its treatment. Subjects and Methods: cross-sectional descriptive study and self-comparison before and after treatment, conducted at the Department of Dermatology - Hai Phong University of Medicine and Pharmacy Hospital (6/2024–2/2025). Study subjects: 102 patients with non-fungal seborrheic dermatitis treated with topical tacrolimus. Results: After 4 weeks using topical tacrolimus, complete resolution was achieved in 34.3% (erythema) and 44.1% (scaling); disease severity scores significantly decreased (p<0.001). Adverse effects, mainly mild irritation, reduced from 28.4% (week 1) to 13.7% (week 4). Conclusion: Topical tacrolimus is effective and safe for managing seborrheic dermatitis, particularly facial lesions, with significant symptom improvement after 4 weeks and minimal side effects.